Wordt geladen...
Orthotopic T-Cell Receptor Replacement—An “Enabler” for TCR-Based Therapies
Natural adaptive immunity co-evolved with pathogens over millions of years, and adoptive transfer of non-engineered T cells to fight infections or cancer so far exhibits an exceptionally safe and functional therapeutic profile in clinical trials. However, the personalized nature of therapies using v...
Bewaard in:
| Gepubliceerd in: | Cells |
|---|---|
| Hoofdauteurs: | , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
MDPI
2020
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7348731/ https://ncbi.nlm.nih.gov/pubmed/32492858 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cells9061367 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|